Memorial Sloan-Kettering Cancer Center , New York, has made...

Memorial Sloan-Kettering Cancer Center, New York, has made commitments to Bain VII, a private equity buyout fund, and Landmark X, a venture capital fund of funds that invests in secondary funds, said Michael Gutnick, CIO at the $2 billion endowment. Officials wouldn’t disclose the size of the commitments. Mr. Gutnick said the endowment will make its final private equity commitment of the year later this month, when Charles River XI, an early stage venture cap fund, comes to market. Funding for all three will come from the endowment’s $350 million private equity program.